Network News
Start-up nanoAR receives funding from a federal “exist”-Forschungstransfer grant for its anti-reflective surface technology Most people have been irritated by the reflection of sunlight on their smartphone display or their spectacles. Many solutions are available — but until now none for curved surfaces or situations with a wide range of light incidence angles. Scientists at […]
read more
WMT AG receives financing with participation from L-Bank’s “InnoGrowth BW” program
Marathon Beteiligungs AG is the lead investor, CARMA Funds also participates in €3.67 million round Heidelberg-based WMT AG today announced the completion of an equity financing round totaling €3.63 million. The lead investor, which was able to significantly expand its investment with the InnoGrowth BW program of L-Bank, is Dresden-based Marathon Beteiligungs AG, which is […]
read more
BioMed X launches Women’s Health R&D Accelerator in Heidelberg
Heidelberg, Germany, October 14th, 2025. BioMed X, today announced the launch of XFem Labs, a new Women’s Health R&D Accelerator in Heidelberg. The purpose of this initiative, which is supported by the Gates Foundation, is to establish a world-class women’s health innovation hub that advances early-stage research into scalable solutions for women in need around the world, including […]
read more
Universität Heidelberg: Successful Placement in Times Higher Education Rankings
Ruperto Carola is ranked among the world’s “Top 50” and one of the top three universities in Germany Heidelberg University is one of the top three universities in Germany, ranking third in the 2025/2026 Times Higher Education World University Rankings, which have just been published. In 49th position internationally, it is among the world’s “Top […]
read more
AbbVie US + EU Golden Ticket 2025 – Apply by November 7, 2025
AbbVie is launching a US and Europe based golden ticket. The award consists of one golden ticket, which provides one year of fully paid individual bench, a desk and membership at one of BioLabs’ operating locations in the US, France or Germany. The award is intended for early-stage biotech companies developing therapeutics (not devices) in […]
read more
Two Life Sciences Bridge Awards for Heidelberg researchers
Double success for Heidelberg life sciences: Two of the three prestigious Life Sciences Bridge Awards presented this year go to Heidelberg University’s Medical Faculty. The Aventis Foundation honors infectious disease specialist Dr. Frauke Mücksch and neurologist Dr. Varun Venkataramani for their groundbreaking research. While Mücksch is searching for new ways to one day cure HIV […]
read more
GeneNovate | Call for Application 2025/2026 | APPLICATION DEADLINE: 09.11.2025
Got a startup idea? Curious about entrepreneurship? Then the GeneNovate program is the perfect place to start! Objective GeneNovate is the first nationwide entrepreneurship program in Germany, designed to empower innovators and entrepreneurs in the field of Gene and Cell Therapies (GCT), Biotech and Medicine. The program targets early-career scientists and physicians, such as advanced […]
read more
VectorBuilder Redefines Plasmid Standards with miniVec
Chicago, IL – October 8th, 2025 – VectorBuilder, a global leader in gene delivery technologies and CDMO services, today announced the publication of the miniVec plasmid system, engineered for safer, more efficient, and more scalable development of genetic medicines. The manuscript detailing this breakthrough is now published on BioRxiv. Plasmids have long been a key material […]
read more
Celonic Group and CARBOGEN AMCIS Announce Strategic Alliance to Deliver Fully Integrated ADC Development and Manufacturing Platform
October 7, 2025 Celonic Group one of the leading “pureplay” Biologics CDMO, and The Carbogen Amcis Group, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, today announced a strategic partnership to offer a fully integrated Antibody-Drug Conjugate (ADC) development and manufacturing solution. The alliance combines Celonic’s advanced biologics capabilities with CARBOGEN […]
read more
